These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 28157695)
1. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer. Chen M; Li J; Zhuang C; Cai Z Oncotarget; 2017 Apr; 8(17):28176-28186. PubMed ID: 28157695 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer. Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer. Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855 [TBL] [Abstract][Full Text] [Related]
4. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway. Tuo Z; Zhang J; Xue W Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110 [TBL] [Abstract][Full Text] [Related]
5. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway. Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504. Chen Q; Fu L PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567 [TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis. Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA ABHD11-AS1 interacts with SART3 and regulates CD44 RNA alternative splicing to promote lung carcinogenesis. Wang PS; Liu Z; Sweef O; Xie J; Chen J; Zhu H; Zeidler-Erdely PC; Yang C; Wang Z Environ Int; 2024 Mar; 185():108494. PubMed ID: 38364571 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer development through regulation of miR-133a/SOX4 axis. Lei X; Li L; Duan X Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429229 [TBL] [Abstract][Full Text] [Related]
11. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA. Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687 [TBL] [Abstract][Full Text] [Related]
13. Role of the lncRNA ABHD11-AS Wu DD; Chen X; Sun KX; Wang LL; Chen S; Zhao Y Mol Cancer; 2017 Aug; 16(1):138. PubMed ID: 28818073 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA ABHD11-AS1 promote cells proliferation and invasion of colorectal cancer via regulating the miR-1254-WNT11 pathway. He D; Yue Z; Liu L; Fang X; Chen L; Han H J Cell Physiol; 2019 Jul; 234(7):12070-12079. PubMed ID: 30537177 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma. Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830 [TBL] [Abstract][Full Text] [Related]
16. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer. Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229 [TBL] [Abstract][Full Text] [Related]
17. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer. Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis. Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578 [TBL] [Abstract][Full Text] [Related]
19. LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316. Wang F; Zu Y; Huang W; Chen H; Xie H; Yang Y Biochem Biophys Res Commun; 2018 Sep; 504(1):171-176. PubMed ID: 30177388 [TBL] [Abstract][Full Text] [Related]
20. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]